- $25.34bn
- $25.27bn
- $7.28bn
- 87
- 26
- 68
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,770 | 5,055 | 6,280 | 7,274 | 7,284 |
Cost of Revenue | |||||
Gross Profit | 1,157 | 1,223 | 1,668 | 2,030 | 1,992 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 4,403 | 4,654 | 5,652 | 6,443 | 6,489 |
Operating Profit | 367 | 401 | 629 | 832 | 795 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 363 | 400 | 628 | 829 | 790 |
Provision for Income Taxes | |||||
Net Income After Taxes | 296 | 323 | 499 | 704 | 634 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 246 | 270 | 419 | 601 | 536 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 226 | 246 | 382 | 550 | 499 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.5 | 7.01 | 10.8 | 15.4 | 13.7 |
Dividends per Share |